Top Medical News
Pearl Toh, 7 hours ago
Ertugliflozin 15 mg once daily is noninferior to the sulphonylurea glimepiride in HbA1c reduction over 52 weeks in patients with type 2 diabetes (T2D) who are inadequately controlled on metformin, according to the VERTIS SU* trial presented at the EASD 2017 in Lisbon, Portugal.
Roshini Claire Anthony, Yesterday

The addition of the glucagon-like peptide-1 analogue semaglutide to standard of care resulted in sustained reduction in weight and waist circumference in individuals with type 2 diabetes (T2D) with high cardiovascular risk, according to the phase III SUSTAIN 6* trial presented at EASD 2017.

Jairia Dela Cruz, Yesterday
Intranasal delivery of dry powder glucagon in paediatric type 1 diabetes (T1D) patients with moderate to severe hypoglycaemia appears to induce recovery over half an hour, with the rise in blood glucose occurring within 15 minutes, according to a study presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017).
Roshini Claire Anthony, 2 days ago

The addition of the sodium-glucose cotransporters 1 and 2 (SGLT1 and SGLT2) inhibitor sotagliflozin improved glycated haemoglobin levels, systolic blood pressure, and weight in patients with type 1 diabetes (T1D) on insulin therapy, according to findings of the InTandem3* trial presented at EASD 2017.

Jairia Dela Cruz, 2 days ago
Use of continuous glucose monitoring (CGM) in the management of diabetes may lead to performance of fewer self-monitoring blood glucose tests, without any deleterious impact on glycaemic control, according to a study presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017).
Elaine Soliven, 2 days ago
A gluten-free diet (GFD) may help delay the increase of insulin dose in children with newly diagnosed type 1 diabetes mellitus (T1DM), according to a study presented at EASD 2017.
2 days ago
The additional use of intermittent low-energy diet (LED) or daily meal replacements after a mean 10-percent weight loss and 1-year maintenance effectively maintains weight loss in obese patients with knee osteoarthritis for 3 years, according to a recent study.
Special Reports
05 Apr 2017
At a recent lunch symposium held in conjunction with the 1st Malaysian Advances in Women’s Health Congress 2016, Professor Dr Jamiyah Hassan imparted clinical updates and strategies for the optimization of hormone replacement therapy in menopausal women. Highlights from her presentation are summarized below.
16 Mar 2017
Recently, Dr Peter Lin of the Canadian Heart Research Centre spoke on treatment strategies in the management of dyslipidaemia and T2DM at an AstraZeneca-sponsored continuing medical education event. Highlights of his presentations are summarized below.
20 Jan 2017
At the recent Malaysian Osteoporosis Society 2016 Clinical Practice Guideline (CPG) Meeting held on the 8th of October 2016 at Ibis Styles Ipoh, Dr Hew Fen Lee and Professor Dr Chan Siew Pheng presented clinical guidance on the management of osteoporosis, and discussed whether the benefits of treatment outweigh the risks.
04 Jan 2017
At the Diabetes Asia 2016 Conference organized by the National Diabetes Institute, Professor Jean Claude Mbanya presented the case for why gliclazide modified release (MR; Diamicron® MR, Servier) should be the treatment of choice for early and aggressive control of type 2 diabetes (T2D).
16 Dec 2016
BASALOG – Insulin glargine (rDNA) 100 IU/mL soln for inj (cartridge) – CCM Pharmaceuticals
16 Dec 2016
INVOKANA – Canagliflozin hemihydrate 100 mg and 300 mg FC tab – Johnson & Johnson (Janssen)
Pearl Toh, 07 Dec 2016
Preventing hypertension, diabetes, and obesity, which are the major risk factors for heart failure (HF), by ages 45 and 55 years may lower risks of incident HF and prolong HF-free survival, suggests data from the Cardiovascular Disease Lifetime Risk Pooling Project.
Conference Reports
Pearl Toh, 20 Sep 2017
Ertugliflozin 15 mg once daily is noninferior to the sulphonylurea glimepiride in HbA1c reduction over 52 weeks in patients with type 2 diabetes (T2D) who are inadequately controlled on metformin, according to the VERTIS SU* trial presented at the EASD 2017 in Lisbon, Portugal.
Roshini Claire Anthony, 19 Sep 2017

The addition of the glucagon-like peptide-1 analogue semaglutide to standard of care resulted in sustained reduction in weight and waist circumference in individuals with type 2 diabetes (T2D) with high cardiovascular risk, according to the phase III SUSTAIN 6* trial presented at EASD 2017.

Jairia Dela Cruz, 19 Sep 2017
Intranasal delivery of dry powder glucagon in paediatric type 1 diabetes (T1D) patients with moderate to severe hypoglycaemia appears to induce recovery over half an hour, with the rise in blood glucose occurring within 15 minutes, according to a study presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017).
Roshini Claire Anthony, 18 Sep 2017

The addition of the sodium-glucose cotransporters 1 and 2 (SGLT1 and SGLT2) inhibitor sotagliflozin improved glycated haemoglobin levels, systolic blood pressure, and weight in patients with type 1 diabetes (T1D) on insulin therapy, according to findings of the InTandem3* trial presented at EASD 2017.

Jairia Dela Cruz, 18 Sep 2017
Use of continuous glucose monitoring (CGM) in the management of diabetes may lead to performance of fewer self-monitoring blood glucose tests, without any deleterious impact on glycaemic control, according to a study presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017).
Elaine Soliven, 18 Sep 2017
A gluten-free diet (GFD) may help delay the increase of insulin dose in children with newly diagnosed type 1 diabetes mellitus (T1DM), according to a study presented at EASD 2017.
Stephen Padilla, 18 Sep 2017
Increasing the frequency of meals (six-meal pattern), compared with a three-meal pattern, improves glucose metabolism and satiety in obese patients with impaired glucose tolerance (IGT) or type 2 diabetes mellitus (T2DM), according to a 24-week weight maintenance study presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017) in Lisbon, Portugal.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD